For more information or confidential assistance
800-306-3180
se habla español

New Study Highlights Nexium Dangers

Recent large scale epidemiological and retrospective studies have demonstrated links between the use of proton pump inhibitors (PPIs) and an increased risk of renal failure, myocardial infarction and dementia. On top of this, medical experts say that up to 70 percent of patients that take PPIs for treatment of heartburn... Read more »

FDA Invokana Study Finds Potential Amputation Link

The U.S. Food and Drug Administration has issued a new safety alert regarding the type 2 diabetes drug canagliflozin — Invokana and Invokamet. The Agency issued a safety announcement on May 18, notifying patients and the medical community that results of an ongoing clinical trial revealed a higher number of... Read more »

Testosterone Claim Involving Testim Joins MDL 2545

An Arlington, Texas man has filed a testosterone lawsuit against Endo Pharmaceuticals, Inc., Auxilium Pharmaceuticals, Inc. and GlaxoSmithKline, LLC. His lawsuit will join the multidistrict litigation in the Northern District of Illinois. According to his short form complaint, the man was prescribed and began taking Testim in June 2010. In... Read more »

Couple Files Mesothelioma Lawsuit Against Colgate, Pfizer

A Wisconsin couple has filed a lawsuit against the Colgate-Palmolive Company, Pfizer and a number of affiliates, claiming asbestos in some of the companies’ talc products caused the husband to develop mesothelioma. From approximately 1967 through the 1970’s, Steven P. Schultz’s mother used the asbestos-containing Cashmere Bouquet Talcum Powder products... Read more »

Government Office Expresses Concern With FDA Drug Oversight

The federal Food and Drug Administration (FDA) is tasked with the tremendous responsibility of keeping American consumers safe from dangerous drugs and medical devices. Accordingly, the agency has not only implemented strict pre-market testing and screening measures for new products, but it is required to monitor the products after their... Read more »

New Report Warns of 21st Century Cures Act Shortfalls

In December 2015, non-profit group Public Citizen published a report highlighting a provision in the proposed 21st Century Cures Act that could cost taxpayers $12 billion — and that’s just one of the expenses. The report — written by Sammy Almashat and Sarah Sorscher of Public Citizen’s Health Research Group... Read more »

FDA Approval of Xarelto May Have Been Based on False Data

Thousands of Xarelto users have brought federal lawsuits against the drug’s manufacturers alleging that the anticoagulant caused uncontrollable bleeding and severe injuries. Recent reports shed light on a how the drug made it to the market with FDA approval. The anticoagulant’s drug trial was based on what may have been a... Read more »

Louisiana Mother Blames Zofran for Son’s Heart Condition

A Louisiana mother has filed a Zofran lawsuit against GlaxoSmithKline on behalf of her son. Zofran (ondansetron) is a prescription medication used to prevent nausea and vomiting in chemotherapy or radiation patients. It is also commonly used by pregnant women suffering from morning sickness, though it has not received approval... Read more »

FDA Accused of Lax Oversight in Pradaxa Approval Process

A new report from the Project on Government Oversight (POGO) includes serious criticisms of the FDA and the process through which it approved Pradaxa, Boehringer Ingelheim’s widely used, yet highly controversial anticoagulant drug. The comprehensive review of Pradaxa’s path to the American market accuses the regulatory agency of being “lax,... Read more »